Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel

Condition(s) targeted: Epiretinal Membrane; Vitreomacular Traction

Intervention: using ILM forceps alone (Procedure); Breaking and peeling with end-grasping forceps (Procedure)

Phase: N/A

Status: Recruiting

Sponsored by: Michael Debakey Veterans Affairs Medical Center

Official(s) and/or principal investigator(s):
Petros E Carvounis, B.M.B.Ch., F.R.C.S.C., Principal Investigator, Affiliation: Baylor College of Medicine, Michael Debakey VAMC

Overall contact:
Jordan L Heffez, MD, Phone: 713-798-3880, Email: heffez@bcm.edu

Epiretinal membranes (ERM) are cellular membranes on the surface of the retina that result in distortion of the vision (metamorphopsia), and decreased best-corrected visual acuity. They are most frequently found in patients over the age of 50 and have a reported prevalence of 7-12%. [1,2] Epiretinal membranes are caused by posterior vitreous separation, retinal detachment, proliferative vitreoretinopathy, cataract surgery, trauma, inflammation, retinal vascular disease, and idiopathic. [1-4] Epiretinal membrane removal by pars plana vitrectomy combined with internal limiting membrane peeling leads to improved vision, decreased metamorphopsia, and improved quality of life after surgery. [2] Internal limiting membrane (ILM) peel has been associated with decreased rates of epiretinal membrane recurrence and is also performed during vitrectomy for repair of macular holes or vitreomacular traction. [5,6] Internal limiting membrane peeling can be performed by using an instrument to make a break in the membrane followed by peeling with forceps, or by utilizing ILM forceps alone to pinch and peel an unviolated ILM. No study exists comparing different intraoperative techniques used for ILM peeling on visual outcomes and operating time. The investigators hypothesize that using a "pinch and peel" technique will equal outcomes with shorter operating time than other techniques.

1. McDonald HR, Johnson RN, Ai E, Jumper JM, Fu AD. Macular epiretinal membranes. Retina, 4th edition, editor Ryan SJ, Wilkinson CP, 2006, p 2509-2525.

2. Ghazi-Nouri SM, Tranos PG, Rubin GS, Adams ZC, Charteris DG. Vitrectomy and epiretinal membrane peel surgery visual function and quality of life following. 2006;90;559-562; Br. J. Ophthalmol

3. Haritoglu C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. The Effect of Indocyanine-Green on Functional Outcome of Macular Pucker Surgery. AM. J. Ophthal. VOL. 135,NO. 3, 328-337, Mar 2003

4. Hiscott PS, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br. J. Ophthalmol, 1984, 68, 708-715

5. Park DW, Dugel PU, Garda J, Sipperley JO, Thach A, Sneed SR, Blaisdell J. Macular Pucker Removal with and without Internal Limiting Membrane Peeling: Pilot Study. Ophthalmology Volume 110, 1, Jan 2003

6. Kwok AK, Lai TY, Yuen KS. Epiretinal membrane surgery with or without internal limiting membrane peeling. Clinical and Experimental Ophthalmology, 2005, 33: 379-385

Official title: Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel.

Study design: Randomized, Single Blind (Subject), Parallel Assignment

Primary outcome: Change in visual acuity

Secondary outcome: Change in humphrey visual field

Minimum age: 19 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Epiretinal membrane with associated macular thickening or cystoid macular edema

present;

- ETDRS best corrected visual acuity 20/50 or worse attributed to the effects of the

epiretinal membrane;

- Pars plana vitrectomy/membrane peel planned for treatment of the epiretinal membrane;

- Patients older than 19 years of age;

- No co-existent retina pathology or optic neuropathy that may influence the visual

field.

Exclusion Criteria:

- Patient unwilling or unable to provide informed consent;

- Co-existing retina pathology (proliferative diabetic retinopathy, central retinal

vein occlusion, branch retinal vein occlusion, central/branch retinal artery occlusion, ERM secondary to trauma, prior surgery for ERM);

- Co-existing lenticular opacity;

- Optic neuropathy causing a pre-existing visual field defect involving the central 10

degrees of vision.

Jordan L Heffez, MD, Phone: 713-798-3880, Email: heffez@bcm.edu

Michael Debakey VAMC, Houston, Texas 77030, United States; Recruiting
Anita Austin, Phone: 713-798-5756, Email: aaustin@bcm.edu
Petros E Carvounis, B.M.B.Ch., F.R.C.S.C., Principal Investigator
Jordan L Heffez, MD, Sub-Investigator
Andrew J Barkmeier, MD, Sub-Investigator

Baylor College of Medicine, Houston, Texas 77030, United States; Recruiting
Anita Austin, Phone: 713-798-5756, Email: aaustin@bcm.edu
Petros E Carvounis, B.M.B.Ch., F.R.C.S.C., Principal Investigator

Starting date: December 2008
Ending date: May 2010
Last updated: April 30, 2009